Theravance Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $485.6M
Liabilities Breakdown FY2025
Total Liabilities: $188.8M
Asset Breakdown
Total Assets: $485.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $167.8M | 34.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.9M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $311.9M | 64.2% |
Liabilities Breakdown
Total Liabilities: $188.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 1.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $186.3M | 98.6% |